PMID: 40263352

The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a retrospective study.

Yao Siyang, Huang Qiangsong, Zou Yan, Liu Tianqi, Yang Yongyu, Huang Tao, Zhao Yuanquan, Dong Xiaofeng

Scientific reports · 2025

Vol. 15, Issue 1, pp. 13960

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansCarcinoma, HepatocellularLiver NeoplasmsMaleFemaleQuinolinesMiddle AgedRetrospective StudiesAntibodies, Monoclonal, HumanizedPhenylurea Compounds

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.